 |
SYDNEY, June 23, 2025 /PRNewswire/ -- Kaneka Corporation Supplement Division APAC, the world-renowned manufacturer and global supplier of Ubiquinol is thrilled to announce that Kaneka Ubiquinolâ„¢ has been awarded the prestigious Forbes Packaging Marketing Award 2025 at the Natural Health Products New Zealand (NHPNZ) Summit, further elevating the brand's position and stature in the natural health industry across the APAC region.
The win reflects Kaneka Ubiquinol's outstanding efforts in shining the spotlight on the role of mitochondrial health powered by Ubiquinol, in supporting optimal wellbeing. The award celebrates the strategic impact, scientific credibility and executional excellence of its multi-channel marketing programs which have worked to reach, engage and build trust with brandholders, healthcare professionals, pharmacists, media and consumers alike. As a result this has helped position mitochondrial health and Ubiquinol as the new frontier of evidence-based wellbeing.
Mitochondria, powered by the naturally occurring antioxidant ubiquinol, are the millions of "powerhouses" found in all cells that generate energy in our body. They are found in the largest concentrations in tissues and organs requiring the highest levels of energy production – heart, brain, liver, lungs, muscles, sperm and ovum. Science shows that from the age of approximately 30 + natural Ubiquinol levels start to decline, which may require supplementation.
Kaneka Ubiquinol's unique globally patented precision yeast fermentation process enables the production of bioidentical Ubiquinol, delivering a premium, clinically proven ingredient that supports mitochondrial health.
Upon receiving the award Tsuyoshi Takakuwa, Head of Marketing & Sales (APAC) Supplemental Nutrition Business Division, Kaneka Corporation, Japan said "this recognition reflects the collective efforts of our marketing, science, R&D teams, healthcare practitioner partners, brandholders, KOLs and, importantly consumers, united by a shared commitment to science, quality, education and a long-term vision to cement Ubiquinol's role as the foundation of mitochondrial health."
On congratulating the team, Kazuki Takita, Oceania & Asia Marketing & Sales Team, Supplement Business Group, Supplement Strategic Unit, added that the award is a powerful testament of the success of the brand's multi-market, multi-channel strategy, which supports Kaneka Ubiquinol's presence and credibility across the APAC region.
"This award illustrates our strategic vision: to position Kaneka Ubiquinolâ„¢ as a trusted ingredient for healthcare professionals, a premium asset for brandholders, and a clinically supported ingredient for consumers seeking high-quality, evidence-based supplementation to support their overall health and wellbeing," he continued.
"Thank you to NHPNZ and the judging panel for this honour and we extend our congratulations to all the other finalists and winners."
ABOUT KANEKA UBIQUINOLâ„¢
Kaneka Ubiquinolâ„¢ is supported by 100+ scientific studies, 80+ patents and 45+ years of research, with applications spanning mitochondrial health, cardiovascular health, cognitive function, women's health, reproductive health, energy production, sleep, stress, healthy ageing and vitality.
Kaneka Ubiquinol's impeccable standards are built on the Japanese philosophy of 'Kaizen' meaning 'a commitment to quality, efficiency and pursuit of perfection', from the company's rigorous commitment to quality and research, to their outstanding stakeholder support. Its strict adherence to the highest manufacturing standards guarantees a stable ingredient, free from impurities, meeting rigorous standards and sustainability requirements, setting the global benchmark for production quality. Listed in over 50 countries in 1000+ practitioner and OTC nutraceutical brands since 2006.
Kaneka Ubiquinolâ„¢ is the proud winner of multiple awards including:
- Natural Health Products New Zealand Marketing Award 2025
- Complementary Medicines Australia Raw Material Supplier of the Year Award 2024
- Nutraingredients-Asia Healthy Ageing Ingredient of the Year Award 2024
- FFWS Ingredient Award - Cardiovascular Health Award 2024
- FFWS Ingredient Award - Healthy Ageing 2025
www.ubiquinol.net.au
SYDNEY, June 23, 2025 /PRNewswire/ -- Kaneka Corporation Supplement Division APAC, the world-renowned manufacturer and global supplier of Ubiquinol is thrilled to announce that Kaneka Ubiquinolâ„¢ has been awarded the prestigious Forbes Packaging Marketing Award 2025 at the Natural Health Products New Zealand (NHPNZ) Summit, further elevating the brand's position and stature in the natural health industry across the APAC region.
The win reflects Kaneka Ubiquinol's outstanding efforts in shining the spotlight on the role of mitochondrial health powered by Ubiquinol, in supporting optimal wellbeing. The award celebrates the strategic impact, scientific credibility and executional excellence of its multi-channel marketing programs which have worked to reach, engage and build trust with brandholders, healthcare professionals, pharmacists, media and consumers alike. As a result this has helped position mitochondrial health and Ubiquinol as the new frontier of evidence-based wellbeing.
Mitochondria, powered by the naturally occurring antioxidant ubiquinol, are the millions of "powerhouses" found in all cells that generate energy in our body. They are found in the largest concentrations in tissues and organs requiring the highest levels of energy production – heart, brain, liver, lungs, muscles, sperm and ovum. Science shows that from the age of approximately 30 + natural Ubiquinol levels start to decline, which may require supplementation.
Kaneka Ubiquinol's unique globally patented precision yeast fermentation process enables the production of bioidentical Ubiquinol, delivering a premium, clinically proven ingredient that supports mitochondrial health.
Upon receiving the award Tsuyoshi Takakuwa, Head of Marketing & Sales (APAC) Supplemental Nutrition Business Division, Kaneka Corporation, Japan said "this recognition reflects the collective efforts of our marketing, science, R&D teams, healthcare practitioner partners, brandholders, KOLs and, importantly consumers, united by a shared commitment to science, quality, education and a long-term vision to cement Ubiquinol's role as the foundation of mitochondrial health."
On congratulating the team, Kazuki Takita, Oceania & Asia Marketing & Sales Team, Supplement Business Group, Supplement Strategic Unit, added that the award is a powerful testament of the success of the brand's multi-market, multi-channel strategy, which supports Kaneka Ubiquinol's presence and credibility across the APAC region.
"This award illustrates our strategic vision: to position Kaneka Ubiquinolâ„¢ as a trusted ingredient for healthcare professionals, a premium asset for brandholders, and a clinically supported ingredient for consumers seeking high-quality, evidence-based supplementation to support their overall health and wellbeing," he continued.
"Thank you to NHPNZ and the judging panel for this honour and we extend our congratulations to all the other finalists and winners."
ABOUT KANEKA UBIQUINOLâ„¢
Kaneka Ubiquinolâ„¢ is supported by 100+ scientific studies, 80+ patents and 45+ years of research, with applications spanning mitochondrial health, cardiovascular health, cognitive function, women's health, reproductive health, energy production, sleep, stress, healthy ageing and vitality.
Kaneka Ubiquinol's impeccable standards are built on the Japanese philosophy of 'Kaizen' meaning 'a commitment to quality, efficiency and pursuit of perfection', from the company's rigorous commitment to quality and research, to their outstanding stakeholder support. Its strict adherence to the highest manufacturing standards guarantees a stable ingredient, free from impurities, meeting rigorous standards and sustainability requirements, setting the global benchmark for production quality. Listed in over 50 countries in 1000+ practitioner and OTC nutraceutical brands since 2006.
Kaneka Ubiquinolâ„¢ is the proud winner of multiple awards including:
- Natural Health Products New Zealand Marketing Award 2025
- Complementary Medicines Australia Raw Material Supplier of the Year Award 2024
- Nutraingredients-Asia Healthy Ageing Ingredient of the Year Award 2024
- FFWS Ingredient Award - Cardiovascular Health Award 2024
- FFWS Ingredient Award - Healthy Ageing 2025
www.ubiquinol.net.au
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
KANEKA UBIQUINOL™ WINS COVETED MARKETING AWARD 2025 AT NATURAL HEALTH PRODUCTS NEW ZEALAND SUMMIT
KANEKA UBIQUINOL™ WINS COVETED MARKETING AWARD 2025 AT NATURAL HEALTH PRODUCTS NEW ZEALAND SUMMIT
KUALA LUMPUR, Malaysia, Jan. 12, 2026 /PRNewswire/ -- Elitery Global Technology Sdn. Bhd., a subsidiary of PT Data Sinergitama Jaya Tbk, proudly announces that it has been awarded the prestigious Malaysia Digital (MD) Status by the Malaysia Digital Economy Corporation (MDEC). This recognition marks an important milestone in Elitery's regional growth journey and reaffirms the company's commitment to advancing the digital economy through innovation, technology excellence, and strategic collaboration. The MD Status, conferred by the Government of Malaysia, is awarded to companies that meet stringent criteria in driving approved digital activities and contributing to the nation's digital transformation agenda.
"Receiving the Malaysia Digital Status is a major milestone for Elitery Global Technology Sdn. Bhd.," said Kresna Adiprawira, Director of Elitery Global Technology Sdn. Bhd. "This recognition not only validates our current digital initiatives but also opens up greater opportunities to accelerate our growth, enhance our capabilities, and strengthen our contribution to Malaysia's digital ecosystem."
The MD Status provides Elitery access to key incentives and privileges under the Malaysia Digital Bill of Guarantees (BoGs). These benefits include the flexibility to hire both local and foreign talent, full freedom of ownership, and the ability to raise and borrow capital globally to support its expansion across the region. Furthermore, the company is allowed to invest in foreign currency assets both in Malaysia and abroad, enabling stronger business diversification and growth. Beyond financial advantages such as income tax exemptions and investment tax allowances, the MD Status connects Elitery to Malaysia's thriving digital ecosystem through business-matching initiatives, partnership opportunities, and grant facilitation.
This recognition will empower Elitery Global Technology Sdn. Bhd. to expand its digital product portfolio, invest further in local talent, and strengthen its presence across regional markets. As part of this commitment, the company will continue to uphold full compliance with all MD Status requirements, including the annual submission of the Self-Declaration Form (SDF), ensuring sustained alignment with Malaysia's digital economy standards.
About Elitery
Elitery (IDX: ELIT) is a premier IT Managed Services provider specializing in cloud and cybersecurity. A strategic Google Cloud partner and two-time Public Sector Partner of the Year (2023-2024), ELIT leverages 14+ years of expertise to drive secure digital transformation across Asia-Pacific.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
A New Era of Digital Innovation: Elitery Global Technology Sdn. Bhd. Granted Malaysia Digital (MD) Status
